Eli Lilly receives UK marketing approval for ulcerative colitis treatment June 29, 2023 AutoBot News 0 Eli Lilly has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization (MA) for its ulcerative colitis treatment, Mirikizumab.